Literature DB >> 35491056

Cell senescence and malignant transformation in the inherited bone marrow failure syndromes: Overlapping pathophysiology with therapeutic implications.

Emma M Groarke1, Rodrigo T Calado2, Johnson M Liu3.   

Abstract

Fanconi anemia, telomeropathies and ribosomopathies are members of the inherited bone marrow failure syndromes, rare genetic disorders that lead to failure of hematopoiesis, developmental abnormalities, and cancer predisposition. While each disorder is caused by different genetic defects in seemingly disparate processes of DNA repair, telomere maintenance, or ribosome biogenesis, they appear to lead to a common pathway characterized by premature senescence of hematopoietic stem cells. Here we review the experimental data on senescence and inflammation underlying marrow failure and malignant transformation. We conclude with a critical assessment of current and future therapies targeting these pathways in inherited bone marrow failure syndromes patients. Published by Elsevier Inc.

Entities:  

Keywords:  Fanconi Anemia; Telomere biology disorders; cell senescence; inherited bone marrow failure syndromes; ribosomopathies; somatic mutations

Mesh:

Year:  2022        PMID: 35491056      PMCID: PMC9062194          DOI: 10.1053/j.seminhematol.2022.01.003

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.754


  59 in total

1.  Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia.

Authors:  R T Calado; J N Cooper; H M Padilla-Nash; E M Sloand; C O Wu; P Scheinberg; T Ried; N S Young
Journal:  Leukemia       Date:  2011-10-18       Impact factor: 11.528

Review 2.  Hallmarks of Cellular Senescence.

Authors:  Alejandra Hernandez-Segura; Jamil Nehme; Marco Demaria
Journal:  Trends Cell Biol       Date:  2018-02-21       Impact factor: 20.808

3.  Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.

Authors:  Sladana Bursać; Maja Cokarić Brdovčak; Martin Pfannkuchen; Ines Orsolić; Lior Golomb; Yan Zhu; Chen Katz; Lilyn Daftuar; Kristina Grabušić; Iva Vukelić; Vedrana Filić; Moshe Oren; Carol Prives; Siniša Volarevic
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-20       Impact factor: 11.205

4.  Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.

Authors:  R K Rathbun; G R Faulkner; M H Ostroski; T A Christianson; G Hughes; G Jones; R Cahn; R Maziarz; G Royle; W Keeble; M C Heinrich; M Grompe; P A Tower; G C Bagby
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

Review 5.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

Review 6.  Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells.

Authors:  Lauren D Van Wassenhove; Daria Mochly-Rosen; Kenneth I Weinberg
Journal:  Mol Genet Metab       Date:  2016-07-15       Impact factor: 4.797

7.  Individualized risks of first adverse events in patients with Fanconi anemia.

Authors:  Philip S Rosenberg; Yi Huang; Blanche P Alter
Journal:  Blood       Date:  2004-04-01       Impact factor: 22.113

8.  The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy.

Authors:  Shyam Sushama Jose; Federico Tidu; Petra Burilova; Tomas Kepak; Kamila Bendickova; Jan Fric
Journal:  Front Genet       Date:  2018-08-29       Impact factor: 4.599

Review 9.  Cancer Biogenesis in Ribosomopathies.

Authors:  Sergey O Sulima; Kim R Kampen; Kim De Keersmaecker
Journal:  Cells       Date:  2019-03-11       Impact factor: 6.600

10.  Sister chromatid telomere fusions, but not NHEJ-mediated inter-chromosomal telomere fusions, occur independently of DNA ligases 3 and 4.

Authors:  Kate Liddiard; Brian Ruis; Taylor Takasugi; Adam Harvey; Kevin E Ashelford; Eric A Hendrickson; Duncan M Baird
Journal:  Genome Res       Date:  2016-03-03       Impact factor: 9.043

View more
  1 in total

Review 1.  Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders.

Authors:  Jack Bleesing
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.